#imidresearch resultados da pesquisa

🧬 What is #DocTISProject? 🩺 #IMIDs affect millions worldwide, but not all patients respond in the same way. 🔬 DocTIS combines clinical and molecular data with systems biology to advance more personalised treatments. 🔎 Learn more: doctis.eu #IMIDResearch

DoctisEU's tweet image. 🧬 What is #DocTISProject?

🩺 #IMIDs affect millions worldwide, but not all patients respond in the same way.

🔬 DocTIS combines clinical and molecular data with systems biology to advance more personalised treatments.

🔎 Learn more: doctis.eu

#IMIDResearch

The webinar on "Discovery of Combination Therapies for Immune-Mediated Inflammatory Diseases" was also supported by: - @UniVerona - @ChariteBerlin - @hudsonalpha - @IMIDomics - @zabala_eu #IMIDs #AutoimmuneTherapies #IMIDResearch


🎄 As Christmas approaches, the #DocTISProject reflects on a year of collaboration and progress in #IMIDResearch. 🔬 We continue working towards better, more personalised #AutoimmuneTherapies for people living with #IMIDs. 🔗 Learn more: doctis.eu #IMID

DoctisEU's tweet image. 🎄 As Christmas approaches, the #DocTISProject reflects on a year of collaboration and progress in #IMIDResearch.

🔬 We continue working towards better, more personalised #AutoimmuneTherapies for people living with #IMIDs.

🔗 Learn more: doctis.eu

#IMID

👀 Curious about what we’re doing in immune-mediated inflammatory diseases across Europe? 📹 Watch this presentation by our Single Cell Genomics Group Leader at CNAG, @hoheyn, under the umbrella of the DOCTIS Project⬇️ 📎 Full video: doctis.eu/relive-doctis-… #IMIDResearch

💊 Advancing combination therapies for #IMIDs requires robust molecular data and strong clinical–research integration. 📢 Dr @hoheyn (@cnag_eu) presented Work Package 4 at the #DocTISProject webinar, focusing on molecular data generation from IMID Biobank patients. #IMID



🌍DocTIS: in the final stretch to revolutionise the treatment of immune-mediated inflammatory diseases 🔬After 5 years of research, we are now focusing on clinical trials to develop innovative and personalised medicine doctis.eu/revolutionize-… #AutoimmuneTherapies #IMIDResearch

cnag_eu's tweet image. 🌍DocTIS: in the final stretch to revolutionise the treatment of immune-mediated inflammatory diseases

🔬After 5 years of research, we are now focusing on clinical trials to develop innovative and personalised medicine

doctis.eu/revolutionize-…
#AutoimmuneTherapies #IMIDResearch

Today, we participated in the @DoctisEU 5th General Assembly meeting (@VHIR_) 🗣️@hoheyn, our Single Cell Genomics Group Leader, presented the results of WP4, which focuses on molecular data generation and our latest advancements #IMID #IMIDResearch #DocTISProject

cnag_eu's tweet image. Today, we participated in the @DoctisEU 5th General Assembly meeting (@VHIR_)

🗣️@hoheyn, our Single Cell Genomics Group Leader, presented the results of WP4, which focuses on molecular data generation and our latest advancements

#IMID #IMIDResearch #DocTISProject
cnag_eu's tweet image. Today, we participated in the @DoctisEU 5th General Assembly meeting (@VHIR_)

🗣️@hoheyn, our Single Cell Genomics Group Leader, presented the results of WP4, which focuses on molecular data generation and our latest advancements

#IMID #IMIDResearch #DocTISProject

🧬 What is #DocTISProject? 🩺 #IMIDs affect millions worldwide, but not all patients respond in the same way. 🔬 DocTIS combines clinical and molecular data with systems biology to advance more personalised treatments. 🔎 Learn more: doctis.eu #IMIDResearch

DoctisEU's tweet image. 🧬 What is #DocTISProject?

🩺 #IMIDs affect millions worldwide, but not all patients respond in the same way.

🔬 DocTIS combines clinical and molecular data with systems biology to advance more personalised treatments.

🔎 Learn more: doctis.eu

#IMIDResearch

👀 Curious about what we’re doing in immune-mediated inflammatory diseases across Europe? 📹 Watch this presentation by our Single Cell Genomics Group Leader at CNAG, @hoheyn, under the umbrella of the DOCTIS Project⬇️ 📎 Full video: doctis.eu/relive-doctis-… #IMIDResearch

doctis.eu

Relive the DocTIS webinar: "Discovery of combination therapies for Immune-Mediated Inflammatory...

In February 2025, the DocTIS project hosted an insightful webinar during one of its General Assemblies, marking a key milestone as the initiative enters its

💊 Advancing combination therapies for #IMIDs requires robust molecular data and strong clinical–research integration. 📢 Dr @hoheyn (@cnag_eu) presented Work Package 4 at the #DocTISProject webinar, focusing on molecular data generation from IMID Biobank patients. #IMID



🎄 As Christmas approaches, the #DocTISProject reflects on a year of collaboration and progress in #IMIDResearch. 🔬 We continue working towards better, more personalised #AutoimmuneTherapies for people living with #IMIDs. 🔗 Learn more: doctis.eu #IMID

DoctisEU's tweet image. 🎄 As Christmas approaches, the #DocTISProject reflects on a year of collaboration and progress in #IMIDResearch.

🔬 We continue working towards better, more personalised #AutoimmuneTherapies for people living with #IMIDs.

🔗 Learn more: doctis.eu

#IMID

The webinar on "Discovery of Combination Therapies for Immune-Mediated Inflammatory Diseases" was also supported by: - @UniVerona - @ChariteBerlin - @hudsonalpha - @IMIDomics - @zabala_eu #IMIDs #AutoimmuneTherapies #IMIDResearch


Nenhum resultado para "#imidresearch"

🎄 As Christmas approaches, the #DocTISProject reflects on a year of collaboration and progress in #IMIDResearch. 🔬 We continue working towards better, more personalised #AutoimmuneTherapies for people living with #IMIDs. 🔗 Learn more: doctis.eu #IMID

DoctisEU's tweet image. 🎄 As Christmas approaches, the #DocTISProject reflects on a year of collaboration and progress in #IMIDResearch.

🔬 We continue working towards better, more personalised #AutoimmuneTherapies for people living with #IMIDs.

🔗 Learn more: doctis.eu

#IMID

🧬 What is #DocTISProject? 🩺 #IMIDs affect millions worldwide, but not all patients respond in the same way. 🔬 DocTIS combines clinical and molecular data with systems biology to advance more personalised treatments. 🔎 Learn more: doctis.eu #IMIDResearch

DoctisEU's tweet image. 🧬 What is #DocTISProject?

🩺 #IMIDs affect millions worldwide, but not all patients respond in the same way.

🔬 DocTIS combines clinical and molecular data with systems biology to advance more personalised treatments.

🔎 Learn more: doctis.eu

#IMIDResearch

Today, we participated in the @DoctisEU 5th General Assembly meeting (@VHIR_) 🗣️@hoheyn, our Single Cell Genomics Group Leader, presented the results of WP4, which focuses on molecular data generation and our latest advancements #IMID #IMIDResearch #DocTISProject

cnag_eu's tweet image. Today, we participated in the @DoctisEU 5th General Assembly meeting (@VHIR_)

🗣️@hoheyn, our Single Cell Genomics Group Leader, presented the results of WP4, which focuses on molecular data generation and our latest advancements

#IMID #IMIDResearch #DocTISProject
cnag_eu's tweet image. Today, we participated in the @DoctisEU 5th General Assembly meeting (@VHIR_)

🗣️@hoheyn, our Single Cell Genomics Group Leader, presented the results of WP4, which focuses on molecular data generation and our latest advancements

#IMID #IMIDResearch #DocTISProject

🌍DocTIS: in the final stretch to revolutionise the treatment of immune-mediated inflammatory diseases 🔬After 5 years of research, we are now focusing on clinical trials to develop innovative and personalised medicine doctis.eu/revolutionize-… #AutoimmuneTherapies #IMIDResearch

cnag_eu's tweet image. 🌍DocTIS: in the final stretch to revolutionise the treatment of immune-mediated inflammatory diseases

🔬After 5 years of research, we are now focusing on clinical trials to develop innovative and personalised medicine

doctis.eu/revolutionize-…
#AutoimmuneTherapies #IMIDResearch

Loading...

Something went wrong.


Something went wrong.